PE20090805A1 - COMBINACION DE DROSPIRENONA Y 17ß-ESTRADIOL COMO CONTRACEPTIVO ORAL - Google Patents

COMBINACION DE DROSPIRENONA Y 17ß-ESTRADIOL COMO CONTRACEPTIVO ORAL

Info

Publication number
PE20090805A1
PE20090805A1 PE2008000621A PE2008000621A PE20090805A1 PE 20090805 A1 PE20090805 A1 PE 20090805A1 PE 2008000621 A PE2008000621 A PE 2008000621A PE 2008000621 A PE2008000621 A PE 2008000621A PE 20090805 A1 PE20090805 A1 PE 20090805A1
Authority
PE
Peru
Prior art keywords
combination
drospirenone
estradiol
oral contraceptive
contraceptive
Prior art date
Application number
PE2008000621A
Other languages
English (en)
Inventor
Vladimir Hanes
Hartmut Blode
Rolf Schurmann
Bernd Dusterberg
Joachim Marr
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39745001&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20090805(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of PE20090805A1 publication Critical patent/PE20090805A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

REFERIDA A UNA COMBINACION FARMACEUTICA QUE COMPRENDE ENTRE 2,0 MG Y 3,0 MG DE DROSPIRENONA Y ENTRE 1,0 MG Y 2,0 MG DE 17BETA-ESTRADIOL, DONDE ADEMAS DEL ESTROGENO Y LA DROSPIRENONA DICHA COMBINACION TAMBIEN PUEDE CONTENER TETRAHIDROFOLATO Y METAFOLINA. DICHA COMBINACION ES UTIL EN LA CONTRACEPCION ORAL FEMENINA
PE2008000621A 2007-04-05 2008-04-07 COMBINACION DE DROSPIRENONA Y 17ß-ESTRADIOL COMO CONTRACEPTIVO ORAL PE20090805A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91032607P 2007-04-05 2007-04-05
US3528508P 2008-03-10 2008-03-10
US4049408P 2008-03-28 2008-03-28

Publications (1)

Publication Number Publication Date
PE20090805A1 true PE20090805A1 (es) 2009-07-25

Family

ID=39745001

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008000621A PE20090805A1 (es) 2007-04-05 2008-04-07 COMBINACION DE DROSPIRENONA Y 17ß-ESTRADIOL COMO CONTRACEPTIVO ORAL

Country Status (15)

Country Link
US (1) US20090023693A1 (es)
EP (1) EP2150257A2 (es)
JP (1) JP2010523512A (es)
CN (1) CN101674837A (es)
AR (1) AR065971A1 (es)
AU (1) AU2008235006A1 (es)
BR (1) BRPI0810049A2 (es)
CA (1) CA2683093A1 (es)
CL (1) CL2008000999A1 (es)
IL (1) IL201302A0 (es)
MX (1) MX2009010763A (es)
PE (1) PE20090805A1 (es)
TW (1) TW200904452A (es)
UY (1) UY31010A1 (es)
WO (1) WO2008122439A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
LT2419108T (lt) * 2009-04-14 2016-12-27 Laboratoire Hra Pharma Kontracepcijos pagal poreikį būdas
EP2558076B1 (en) * 2010-04-15 2014-12-24 Bayer Intellectual Property GmbH Low-dosed solid oral dosage forms for hrt
WO2011128336A1 (en) * 2010-04-15 2011-10-20 Bayer Pharma Aktiengesellschaft Very low-dosed solid oral dosage forms for hrt
AU2016282863B2 (en) * 2015-06-23 2021-05-27 Laboratorios Leon Farma Sa Drospirenone-based contraceptive for a female patient affected with excess weight

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1380301T3 (da) * 1999-08-31 2009-04-20 Bayer Schering Pharma Ag Farmaceutisk sammensætning af ethinylestradiol og drospirenon til anvendelse som svangerskabsforebyggende middel
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
UY29527A1 (es) * 2005-05-13 2006-12-29 Schering Ag Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.

Also Published As

Publication number Publication date
JP2010523512A (ja) 2010-07-15
EP2150257A2 (en) 2010-02-10
BRPI0810049A2 (pt) 2015-05-05
TW200904452A (en) 2009-02-01
UY31010A1 (es) 2008-11-28
US20090023693A1 (en) 2009-01-22
CN101674837A (zh) 2010-03-17
CL2008000999A1 (es) 2008-10-10
WO2008122439A2 (en) 2008-10-16
MX2009010763A (es) 2009-10-28
CA2683093A1 (en) 2008-10-16
AR065971A1 (es) 2009-07-15
AU2008235006A1 (en) 2008-10-16
IL201302A0 (en) 2010-05-31
WO2008122439A3 (en) 2009-07-23

Similar Documents

Publication Publication Date Title
MX2012003551A (es) Tabletas transformables via oral.
PE20120860A1 (es) Combinacion farmaceutica que comprende levonorgestrel en combinacion con piroxicam, indometacina o diclofenaco
PE20080273A1 (es) Composicion farmaceutica que contiene un progestageno, un estrogeno y un acido tetrahidrofolico
AR032204A1 (es) Complejos de inclusion de ciclodextrina-drospirenona
CR10732A (es) Uso de valerato de estradiol o 17 b- estradiol en combinacion con dienogest en una terapia oral para mantener y / o incrementar la libido femenina
NI201000183A (es) Regímenes de dosificación de antiprogestina.
MX2010004353A (es) Combinación anticonceptiva oral entiemética.
GT200800038A (es) Metodo para prevenir la contracepción hormonal contra demanda
CR11493A (es) Sistema de administracion vaginal
BR112014031914A2 (pt) cápsula de estradiol solúvel para inserção vaginal
AR054123A1 (es) Composicion farmaceutica que contienen gestagenos y/o estrogenos y 5-metil-(6s)-tetrahidrofolato
CY1124914T1 (el) Στερεες φαρμακευτικες συνθεσεις που περιεχουν αναστολεα ιντεγκρασης
PE20181523A1 (es) Tratamiento de lupus nefritis usando laquinimod
AR054525A1 (es) Composiciones y metodos para eltratamiento de sintomas relacionados con el ciclo
PE20090805A1 (es) COMBINACION DE DROSPIRENONA Y 17ß-ESTRADIOL COMO CONTRACEPTIVO ORAL
SV2017005602A (es) Anticonceptivos a base de drospirenona para paciente femenina afectada con exceso de peso
CO6270217A2 (es) Formulaciones galenicas de alisquireno y valsartan
MX2010005198A (es) Composiciones liquidas que comprenden valsartan.
PE20080400A1 (es) Composicion farmaceutica para la anticoncepcion y para reducir el riesgo de malformaciones congenitas
AR095691A1 (es) FORMULACIÓN DE L-5-METILTETRAHIDROFOLATO DE CALCIO AMORFO (L-5-MTHF-Ca), PROCEDIMIENTO, USO
DOP2007000122A (es) Forma farmacologica peroral para anticoncepcion
AR049220A1 (es) Uso de 7-ter-butoxiiminometilcamptotecina en la preparacion de un medicamento util para el tratamiento de neoplasmas uterinos
UA108865C2 (uk) Парентеральна фармацевтична композиція у вигляді суспензії уповільненого вивільнення, у низькій та наднизькій дозованій формі, у гормональній терапії при клімактеричному синдромі
PE20091695A1 (es) COMBINACION FARMACEUTICA DE DROSPIRENONA Y 17ß-ESTRADIOL
CO2019000538A2 (es) Métodos de fitoterapia para la mejora del sueño, la interacción social, la inquietud o preocupación campo de la divulgación

Legal Events

Date Code Title Description
FC Refusal